En español
NIDA

Menu

Messages From the Director

Communities Across the Country Are Trying to Respond to Increased Abuse of Methamphetamine, a Powerfully Addictive Stimulant

NIDA Director Nora Volkow

April 2005

The National Institute on Drug Abuse (NIDA) has long recognized the danger of methamphetamine abuse, and has actively supported research on this and related drugs. Understanding methamphetamine's effects on the brain and behavior is critical to developing both prevention and treatment strategies.

Methamphetamine is a long-acting and very potent stimulant drug. It can be snorted, swallowed, injected, or smoked, and it is frequently taken in combination with other drugs. Like other drugs of abuse, methamphetamine produces a sense of euphoria by increasing the release of dopamine in the brain's reward centers.

When dopamine is liberated in such high concentrations, it can damage dopamine cells. Indeed, several studies in laboratory animals have corroborated this. In humans, imaging studies have shown that methamphetamine abusers show abnormalities in dopamine function resulting in impairments in movement and cognitive function that are similar, though of a lesser severity, to those seen in patients with Parkinson's disease. The good news is that unlike Parkinson's disease, where the damage to the brain cannot be reversed, with protracted abstinence from methamphetamine, there is some return of function. This further highlights the importance of instituting treatment for methamphetamine abusers to maximize their chances of a successful recovery.

There are other dangerous effects of methamphetamine. The large increases in dopamine produced by methamphetamine can trigger psychosis that in some instances persists months after drug use has stopped. Also, because methamphetamine affects the contraction of blood vessels it can result in heart attacks and strokes in relatively young patients.

In addition to its effects on the brain, methamphetamine use is inextricably linked to risky sexual behaviors, thus increasing the risk for transmission of infectious diseases, including HIV. The recent case of a methamphetamine abuser with a particularly virulent strain of HIV is a sobering reminder of this connection. Those who inject the drug risk contracting HIV through the sharing of contaminated equipment, and methamphetamine's physiological effects may also favor HIV transmission and progression. Preliminary studies suggest that HIV-positive methamphetamine abusers who are on antiretroviral therapy are at greater risk of progressing to AIDS than non-users. Furthermore, interactions between methamphetamine and HIV itself may lead to greater neuronal damage and functional impairment.

Methamphetamine addiction can be treated successfully using currently available behavioral treatments and NIDA is also investing in the development of new medications for methamphetamine addiction. NIDA also is pursuing the development of an immunization strategy based on monoclonal antibodies for the treatment of methamphetamine overdose.

In addition to funding research in this important area, NIDA has a great deal of information on its website about the health effects of methamphetamine abuse that we hope you will find helpful.

Sincerely,

Nora D. Volkow, M.D.
Director

Read my Senate Testimony on Methamphetamine from April 21, 2005.

View additional NIDA information on Metamphetamine.

This page was last updated April 2005

Messages from the Director

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Mar 2012

Feb 2012

Nov 2011

Sep 2011

Aug 2011

Jun 2011

May 2011

Feb 2011

Jan 2011

Dec 2010

Oct 2010

Apr 2010

Dec 2009

May 2009

Feb 2009

Dec 2008

Sep 2008

Aug 2008

Jan 2008

May 2007

Feb 2007

Jul 2006

Jun 2006

Oct 2005

Sep 2005

Aug 2005

Apr 2005

Mar 2005

Apr 2004

Mar 2004

    Featured Publication

    Featured Publication

    Drugs, Brains, and Behavior - The Science of Addiction

    As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.